Skip to content

Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02874261
Enrollment
10
Registered
2016-08-22
Start date
2015-05-31
Completion date
2017-06-30
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity, Sleep Disorders

Brief summary

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of passive exercise. The frequency of the translation (up to 180 cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by the patient or health care professional. The science behind the therapeutic effects of WBPA still remains largely unknown. The investigators are observing how WBPA may impact on sleep and activity in individuals with Parkinson's disease.

Detailed description

Sleep disturbances are common in individuals with Parkinson's Disease. Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of passive exercise. WBPA has been shown in previous studies to increase nitric oxide. Increased levels of nitric oxide have been shown to improve sleep patterns in other populations. The current pilot study will investigate how WBPA will impact upon sleep disturbances in subjects with Parkinson's disease who suffer from abnormal sleep patterns. The investigators will record sleep patterns and activity levels using a Jawbone U3® activity monitor.

Interventions

oscillating bed that the subject will lie on 3 days a week for 45 minutes at 140 cycles per minute.

Sponsors

New York Institute of Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals between the ages of 50-80 * Individuals with Parkinsons disease between the ages of 50-80 * Individuals with a smart phone

Exclusion criteria

* Any condition that prevents you from lying flat on your back, any other neurological condition than Parkinson's disease.

Design outcomes

Primary

MeasureTime frameDescription
Sleep patterns using an activity monitor on the wrist6 weeksThe investigators will record sleep patterns a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index6 weeksThis is a quantitative tool to measure sleep as well as an activity monitor twenty -four hours for seven days at a time
Physical Activity (steps per day using an activity monitor on the wrist)6 weeksThe investigators will record steps per day a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026